What are guidelines for the use of cyclosporine in interstitial cystitis/bladder pain syndrome (IC/BPS)?

Updated: Dec 04, 2020
  • Author: Eric S Rovner, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print

Cyclosporine is recommended by AUA as a fifth-line treatment [3] . CUA guidelines agree that due to its adverse side effects, cyclosporine should be considered a last resort in patients with inflammation and refractory disease. Close monitoring, including measurement of blood pressure, creatinine, and cyclosporine levels, is required. [4]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!